Study of ThermoDox With Standardized Radiofrequency Ablation (RFA) for Treatment of Hepatocellular Carcinoma (HCC)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Chen Min Hua, MD
Peking University Cancer Hospital & Institute
Principal Investigator - Ricardo Lencioni, MD
University of Pisa
Study Chair - Ronnie Tung Ping Poon, MD
Hong Kong University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
61 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Toronto General Hospital
Toronto, Ontario, Canada
- Mengchao Hepatobiliary Hospital of Fujian Medicatl University
Fuzhou, Fujian, China
- Xijing Hospital
Xi'an, Shaanxi, China
- 302 Military Hospital of China
Beijing, China
- Beijing Cancer Hospital, School of Oncology, Peking
Beijing, China
- Beijing Hospital of the Ministry of Health
Beijing, China
- Chinese Pla General Hospital
Beijing, China
- Peking University First Hospital
Beijing, China
- West China Hospital of Sichuan University
Chengdu, China
- the Second Hospital of Dalian Medical University
Dalian, China
- Guangdong General Hospital
Guangdong, China
- Hunan Cancer Hospital
Hunan, China
- the First Hospital of Jilin University
Jilin City, China
- Zhongshan Hospital, Fudan University
Shanghai, China
- the Sixth People'S Hospital of Shenyang
Shenyang, China
- the 3rd Hospital of Tianjing
Tianjin, China
- the First Hospital of Zhejiang
Zhejiang, China
- Zhejiang Cancer Hospital
Zhejiang, China
- Institut Für Diagnostische Und Radiologische Therapie del Uniklinik Frankfurt
Frankfurt, Germany
- Universitaetsklinikum Des Saarlandes, Klik Fuer Allgemeine Chirurgie, Viszeral-, Gefaess Und Kinderchirurgie
Homburg, Germany
- Klinikum Rechts Der Isar, Ii. Medizinische Klinik Und Poliklinik (gastroenterologie)
München, Germany
- Universitätsklinikum Regensburg, Institut Für Röntgendiagnostik
Regensburg, Germany
- Queen Mary Hospital
Hong Kong, Hong Kong
- Cisanello Hospital, Division of Diagnostic Imaging and Intervention
Pisa, Italy
- Department of Radiological Sciences and Bioimaging Catholic University of Rome, "a. Gemelli" Hospital
Rome, Italy
- University Malaya Medical Centre
Kuala Lumpur, Malaysia
- Chinese General Hospital and Medical Center
Manila, Philippines
- St. Lukes Medical Center
Quezon City, Philippines
- Cardinal Santos Medical Center
San Juan City, Philippines
- Singapore General Hospital
Singapore, Singapore
- Pusan National University Hospital
Busan, South Korea
- Kyungpook National University Hospital
Daegu, South Korea
- Kyungpook National University Medical Center
Daegu, South Korea
- Inha University Hospital
Incheon, South Korea
- Samsung Medical Center
Seoul, South Korea
- Seoul National University Hospital
Seoul, South Korea
- Severance Hospital, Yonsei University Health System
Seoul, South Korea
- the Catholic University of Korea, Seoul St.Mary'S Hospital
Seoul, South Korea
- Hospital Madrid Norte Sanchinarro
Madrid, Spain
- Hospital Universitario Marqués de Valdecilla
Santander, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2014
- Primary completion
- 27 Apr 2020
- Completion
- 27 Apr 2020
- Last update posted
- 20 Aug 2024
- Registered enrollment
- 554
- Registry id
- NCT02112656
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.